Award Information
Description of original award (Fiscal Year 2017, $1,000,000)
Signed into law on July 22, 2016, the Comprehensive Addiction and Recovery Act (CARA) is the first major federal substance use disorder treatment and recovery legislation in 40 years and the most comprehensive effort to address the opioid epidemic. CARA establishes a comprehensive, coordinated, and balanced strategy through enhanced grant programs that expand prevention and education efforts while also promoting treatment and recovery. The purpose of this program is to deliver training and technical assistance (TTA) to state and local criminal justice and substance abuse treatment agencies, prescription drug monitoring programs (PDMPs), and their partner agencies in sites selected through the Comprehensive Opioid Abuse Site-based Program (COAP) solicitation. This TTA program is designed to complement the site-based competitive solicitation. This solicitation offers four TTA categories for distinct sets of activities to provide targeted customized TTA to existing and future COAP sites. In category D, BJA seeks an applicant to provide training and technical assistance to all Harold Rogers PDMP site-based grantees (COAP site-based grantees in Categories 5-6).
Brandeis University will use the BJA funds to improve the utility and responsiveness of its TTA services, via the TTAC website, newsletter and News Briefs provided to its listserv, and through one-on-one and small group consultation in a variety of media; and will continue to expand the number and quality of its relationships with national and federal stakeholders. During the grant period of 24 months, TTAC will provide subject matter expertise for two national PDMP and two national COAP meetings, eight regional PDMP meetings, and two MDDD grantee meetings, and multiple webinars and podcasts. In collaboration with BJA, TTAC will complete publications on MDDD grantee progress and outcomes, and innovative PDMP and MDDD practices. TTAC will facilitate the work of the PMIX Work Group and RxCheck Governing Body, and collaborate with BJA and the Category A, B, and C TTA providers working toward a comprehensive response to the opioid crisis.
CA/NCF